- Home
- VXRT
VXRT
Vaxart Inc
as 03-28-2025 4:00pm EST
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.
| Founded: | N/A | Country: | United States |
| Employees: | N/A | City: | SOUTH SAN FRANCISCO |
| Market Cap: | 119.0M | IPO Year: | N/A |
| Target Price: | $3.00 | AVG Volume (30 days): | 1.7M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.33 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.42 - $1.34 | Next Earning Date: | 03-20-2025 |
| Revenue: | $28,700,000 | Revenue Growth: | 288.94% |
| Revenue Growth (this year): | -59.66% | Revenue Growth (next year): | 48.02% |
Latest Vaxart Inc News
VXRT Breaking Stock News: Dive into VXRT Ticker-Specific Updates for Smart Investing
GlobeNewswire
2 days ago
Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Simply Wall St.
7 days ago
Vaxart Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag
Thomson Reuters StreetEvents
8 days ago
Q4 2024 Vaxart Inc Earnings Call
GuruFocus.com
8 days ago
Vaxart Inc (VXRT) Q4 2024 Earnings Call Highlights: Revenue Surge and Strategic Adjustments ...
Zacks
9 days ago
VAXART, INC. (VXRT) Reports Q4 Loss, Lags Revenue Estimates
GlobeNewswire
9 days ago
Vaxart Provides Business Update and Reports Full Year 2024 Financial Results
GlobeNewswire
16 days ago
Vaxart to Host Full Year 2024 Business Update and Financial Results Conference Call on March 20
GlobeNewswire
18 days ago
Vaxart Announces Clinical Trial Initiation of Norovirus Oral Pill Vaccine Candidate
Compare VXRT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "VXRT Vaxart Inc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.